↓ Skip to main content

PER.C6® cells as a serum-free suspension cell platform for the production of high titer poliovirus: A potential low cost of goods option for world supply of inactivated poliovirus vaccine

Overview of attention for article published in Vaccine, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
5 patents
facebook
1 Facebook page

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PER.C6® cells as a serum-free suspension cell platform for the production of high titer poliovirus: A potential low cost of goods option for world supply of inactivated poliovirus vaccine
Published in
Vaccine, October 2012
DOI 10.1016/j.vaccine.2012.10.070
Pubmed ID
Authors

Barbara P. Sanders, Diana Edo-Matas, Jerome H.H.V. Custers, Martin H. Koldijk, Vincent Klaren, Marije Turk, Alfred Luitjens, Wilfried A.M. Bakker, Fons Uytdehaag, Jaap Goudsmit, John A. Lewis, Hanneke Schuitemaker

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 57 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 24%
Student > Ph. D. Student 8 14%
Student > Master 8 14%
Student > Doctoral Student 4 7%
Student > Bachelor 4 7%
Other 7 12%
Unknown 13 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 16%
Biochemistry, Genetics and Molecular Biology 9 16%
Medicine and Dentistry 7 12%
Engineering 6 10%
Immunology and Microbiology 4 7%
Other 8 14%
Unknown 15 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2019.
All research outputs
#3,561,561
of 25,374,917 outputs
Outputs from Vaccine
#3,099
of 16,509 outputs
Outputs of similar age
#26,288
of 202,134 outputs
Outputs of similar age from Vaccine
#44
of 192 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,509 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.7. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,134 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 192 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.